Literature DB >> 20582939

Regression of a congenital mesoblastic nephroma.

Sarah Whittle1, Ankush Gosain, Petagay Y Scott Brown, Lairsa Debelenko, Susana Raimondi, Judith A Wilimas, Jesse J Jenkins, Andrew M Davidoff.   

Abstract

Histologically, the cellular variant of congenital mesoblastic nephroma (CMN) is very similar to another rare tumor of infancy, infantile fibrosarcoma (IFS). In addition to the histologic similarities, these tumor types share cytogenetic abnormalities including translocation t(12;15)(p13;q25). We describe herein the case of a child who did not have immediate surgical resection of a CMN and whose tumor was untreated for 8 months. During that time, the tumor demonstrated a significant degree of regression. The shared translocation with IFS, a tumor with well-documented potential for spontaneous regression, suggests that this genetic abnormality may have contributed to the favorable clinical course. (c) 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 20582939      PMCID: PMC3049946          DOI: 10.1002/pbc.22486

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  19 in total

1.  The ETV6-NTRK3 gene fusion encodes a chimeric protein tyrosine kinase that transforms NIH3T3 cells.

Authors:  D H Wai; S R Knezevich; T Lucas; B Jansen; R J Kay; P H Sorensen
Journal:  Oncogene       Date:  2000-02-17       Impact factor: 9.867

2.  Atypical mesoblastic nephroma. Pathologic characterization of a potentially aggressive variant of conventional congenital mesoblastic nephroma.

Authors:  V V Joshi; J Kasznica; T R Walters
Journal:  Arch Pathol Lab Med       Date:  1986-02       Impact factor: 5.534

3.  Mesoblastic nephroma--a report from the Gesellschaft fur Pädiatrische Onkologie und Hämatologie (GPOH).

Authors:  Rhoikos Furtwaengler; Harald Reinhard; Ivo Leuschner; Jens P Schenk; Ulrich Goebel; Alexander Claviez; Andreas Kulozik; Andreas Zoubek; Dietrich von Schweinitz; Norbert Graf
Journal:  Cancer       Date:  2006-05-15       Impact factor: 6.860

4.  p210BCR/ABL, p190BCR/ABL, and TEL/ABL activate similar signal transduction pathways in hematopoietic cell lines.

Authors:  K Okuda; T R Golub; D G Gilliland; J D Griffin
Journal:  Oncogene       Date:  1996-09-19       Impact factor: 9.867

5.  ETV6-NTRK3 gene fusions and trisomy 11 establish a histogenetic link between mesoblastic nephroma and congenital fibrosarcoma.

Authors:  S R Knezevich; M J Garnett; T J Pysher; J B Beckwith; P E Grundy; P H Sorensen
Journal:  Cancer Res       Date:  1998-11-15       Impact factor: 12.701

6.  Therapy and outcome in 51 children with mesoblastic nephroma: a report of the National Wilms' Tumor Study.

Authors:  C G Howell; H B Othersen; N E Kiviat; P Norkool; J B Beckwith; G J D'Angio
Journal:  J Pediatr Surg       Date:  1982-12       Impact factor: 2.545

7.  Characteristics and survival of 750 children diagnosed with a renal tumor in the first seven months of life: A collaborative study by the SIOP/GPOH/SFOP, NWTSG, and UKCCSG Wilms tumor study groups.

Authors:  Marry M van den Heuvel-Eibrink; Paul Grundy; Norbert Graf; Kathy Pritchard-Jones; Christophe Bergeron; Catherine Patte; Harm van Tinteren; Annie Rey; Carolyn Langford; Jim R Anderson; Jan de Kraker
Journal:  Pediatr Blood Cancer       Date:  2008-06       Impact factor: 3.167

Review 8.  Renal tumors in infants less than 6 months of age.

Authors:  Richard D Glick; M John Hicks; Jed G Nuchtern; David E Wesson; Oluyinka O Olutoye; Darrell L Cass
Journal:  J Pediatr Surg       Date:  2004-04       Impact factor: 2.545

9.  Non-resectable congenital tumors with the ETV6-NTRK3 gene fusion are highly responsive to chemotherapy.

Authors:  Emma McCahon; Poul H B Sorensen; Jeff H Davis; Paul C J Rogers; Kirk R Schultz
Journal:  Med Pediatr Oncol       Date:  2003-05

10.  Expression of mRNA for the neurotrophin receptor trkC in neuroblastomas with favourable tumour stage and good prognosis.

Authors:  M Rydén; R Sehgal; C Dominici; F H Schilling; C F Ibáñez; P Kogner
Journal:  Br J Cancer       Date:  1996-09       Impact factor: 7.640

View more
  2 in total

1.  Congenital mesoblastic nephroma: a single-centre series.

Authors:  M Pachl; G S Arul; I Jester; C Bowen; D Hobin; B Morland
Journal:  Ann R Coll Surg Engl       Date:  2019-09-11       Impact factor: 1.891

2.  Congenital mesoblastic nephroma: Clinical analysis of eight cases and a review of the literature.

Authors:  Zuo-Peng Wang; Kai Li; Kui-Ran Dong; Xian-Min Xiao; Shan Zheng
Journal:  Oncol Lett       Date:  2014-09-01       Impact factor: 2.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.